zolbetuximab
astellas
[]
gi asco 2023, first scoop: zolbetuximab + folfox clearly better than folfox in metastatic gastric cancer. a vast majority of the patients were cps&lt;5. main toxicity: nausea vomiting (claudin is present in the stomach...). great success!!
Full Prof Medical Oncology, GI Oncologist. Gustave Roussy. Paris Saclay University. Lover of sports. Tweets are my own.